Bruno Loillier

Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist

Didier Pruneau, Jean Luc Paquet, J.M. Luccarini et al. · Immunopharmacology · 1999 · 94 citations

Biochemistry, Medicine, Peptide Library +7

Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2

Julie Catusse, Anne Liotard, Bruno Loillier et al. · Biochemical Pharmacology · 2003 · 55 citations

Inflammation, Cytokine, Molecular Immunology +12

Stable expression of human kinin B₁ receptor in 293 cells: pharmacological and functional characterization

S. Bastian, Bruno Loillier, J L Paquet et al. · British Journal of Pharmacology · 1997 · 41 citations · Full text

Molecular Regulation, Dissociation Constant, Immunology +19

Haemodynamic and cardiac effects of kinin B₁ and B₂ receptor stimulation in conscious instrumented dogs

Pierre Bélichard, Bruno Loillier, Jean Luc Paquet et al. · British Journal of Pharmacology · 1996 · 28 citations · Full text

Cardiac Effects, Conscious Instrumented Dogs, Nitric Oxide +22

LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B₂ receptor

Didier Pruneau, Jean‐Michel Luccarini, Chantal Fouchet et al. · British Journal of Pharmacology · 1998 · 27 citations · Full text

Molecular Pharmacology, Molecular Physiology, Lf 16.0335 +15